Emmessar Biotech & Nutrition Ltd
Emmessar Biotech & Nutrition Reports Q2 FY27 Net Profit of Rs. 14.03 Lakhs
RESULTS
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 31 Oct 2026, 04:01 PM IST · BSE ID: 7c82b413-7618-41e0-b89c-ca88a57a281d
View Original BSE Filing (PDF)
💡
In Simple Terms
Emmessar Biotech & Nutrition announced its latest quarterly financial results, reporting a profit of Rs. 14.03 Lakhs.
🤖 AI Summary
- Net Profit after Tax for Q2 FY27 (ended September 30, 2026) was Rs. 14.03 Lakhs.
- Revenue from Operations for the quarter stood at Rs. 10.92 Lakhs.
- Total Income for the quarter ended September 30, 2026, was Rs. 62.50 Lakhs.
- Basic Earnings per Share was Rs. 0.28 for the quarter ended September 30, 2026.
- The Board of Directors approved the unaudited financial results on October 31, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit / (loss) after tax (Quarter ended 30.09.2026)
14.03 Rs. In Lakhs
23.07%
Revenue from Operations (Quarter ended 30.09.2026)
10.92 Rs. In Lakhs
19.08%
Total Income (Quarter ended 30.09.2026)
62.50 Rs. In Lakhs
-0.86%
Basic Earning per Shares (Quarter ended 30.09.2026)
0.28 Rs. In Lakhs
21.74%
Net Profit / (loss) after tax (Half Year ended 30.09.2026)
27.18 Rs. In Lakhs
-4.70%
Revenue from Operations (Half Year ended 30.09.2026)
16.86 Rs. In Lakhs
-8.62%
🏢 How This Affects the Company
The company's primary segment, Healthcare, contributed Rs. 10.92 Lakhs to segment revenue for the quarter ended September 30, 2026.
Net Profit after Tax for Q2 FY27 was Rs. 14.03 Lakhs, with total equity at Rs. 838.66 Lakhs as of September 30, 2026.
The company operates in two segments: Healthcare and Rent on leasehold land, with Healthcare showing Rs. 7.08 Lakhs in segment profit before tax.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results announcement.
👤
Who Is Affected
All shareholders are affected as the results reflect the company's financial performance. Basic EPS for Q2 FY27 was Rs. 0.28.
🔍
Management Signal
The management's approval of the unaudited financial results signals regular compliance with financial reporting obligations.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q3 FY27 results — evaluate sustained profitability and revenue growth.
Segment-wise revenue trends — check growth in Healthcare and Rent on leasehold land.
Breakdown of Other Income — identify components contributing significantly to total income.
MEDIUM RISK
Significant reliance on Other Income and minor revenue decline in H1 FY27 indicate potential volatility in core business performance.
💡 Investor Takeaway
Emmessar Biotech & Nutrition Ltd reported Q2 FY27 Net Profit after Tax of Rs. 14.03 Lakhs, an increase from Rs. 11.40 Lakhs in Q2 FY26. Half-year Revenue from Operations was Rs. 16.86 Lakhs for H1 FY27, down from Rs. 18.45 Lakhs in H1 FY26. Other Income was Rs. 51.58 Lakhs for the quarter.
⚖️ Strengths & Concerns
✅ Positives
- Net Profit after Tax for Q2 FY27 increased to Rs. 14.03 Lakhs, up from Rs. 11.40 Lakhs in Q2 FY26.
- Total Income for Q2 FY27 was Rs. 62.50 Lakhs, marginally lower than Rs. 63.04 Lakhs in Q2 FY26.
⚠️ Concerns
- Revenue from Operations decreased to Rs. 10.92 Lakhs in Q2 FY27 from Rs. 9.17 Lakhs in Q2 FY26, but the half year revenue was Rs. 16.86 Lakhs vs Rs. 18.45 Lakhs in H1 FY26.
- Other Income forms a substantial portion of Total Income, at Rs. 51.58 Lakhs in Q2 FY27 compared to Revenue from Operations at Rs. 10.92 Lakhs.
❓ Frequently Asked Questions
What was Emmessar Biotech & Nutrition's Net Profit after Tax in Q2 FY27?
Emmessar Biotech & Nutrition's Net Profit after Tax for the quarter ended September 30, 2026, was Rs. 14.03 Lakhs.
What was the Revenue from Operations for Emmessar Biotech & Nutrition in Q2 FY27?
The Revenue from Operations for Emmessar Biotech & Nutrition for the quarter ended September 30, 2026, was Rs. 10.92 Lakhs.
What was the Total Income of Emmessar Biotech & Nutrition for the quarter ended September 30, 2026?
The Total Income for Emmessar Biotech & Nutrition for the quarter ended September 30, 2026, was Rs. 62.50 Lakhs.
What was the Basic Earnings per Share (EPS) for Emmessar Biotech & Nutrition in Q2 FY27?
The Basic Earnings per Share for Emmessar Biotech & Nutrition for the quarter ended September 30, 2026, was Rs. 0.28.
Which segments contributed to Emmessar Biotech & Nutrition's revenue in Q2 FY27?
Emmessar Biotech & Nutrition's segment revenue included Rs. 10.92 Lakhs from Healthcare, Rs. 41.33 Lakhs from Rent on leasehold land, and Rs. 10.25 Lakhs from others for Q2 FY27.
Questions based on this BSE filing only. For information purposes.